2199491-27-3
C80H127N10O37P
1851.88
97% min (HPLC)
50 mg
ISO9001
CDMO
Availability: | |
---|---|
Product Description
As an attempt for drug delivery, this compound is an NAG (N-acetyl-D-(+)-glucosamine) derivative that was developed to guide certain compounds into hepatocytes through receptor-mediated endocytosis.
Known as GalXC technology developed by Dicerna, GalNAc is has been explored at HBV pipeline development with RNAi.
content is empty!